Anti-Immune Complex Antibodies are Elicited During Repeated Immunization with HIV Env Immunogens

Sharidan Brown,Aleksandar Antanasijevic,Leigh M. Sewall,Daniel Montiel Garcia,Philip J. M. Brouwer,Rogier W. Sanders,Andrew B. Ward

DOI: https://doi.org/10.1101/2024.03.15.585257

2024-03-17

Abstract:Vaccination strategies against HIV-1 aim to elicit broadly neutralizing antibodies (bnAbs) using prime-boost regimens with HIV envelope (Env) immunogens. Early antibody responses to easily accessible epitopes on these antigens are directed to non-neutralizing epitopes instead of bnAb epitopes. Autologous neutralizing antibody responses appear upon boosting once immunodominant epitopes are saturated. Here we report another type of antibody response that arises after repeated immunizations with HIV Env immunogens and present the structures of six anti-immune complexes discovered using polyclonal epitope mapping. The anti-immune complex antibodies target idiotopes composed of framework regions of antibodies bound to Env. This work sheds light on current vaccine development efforts for HIV, as well as for other pathogens, in which repeated exposure to antigen is required.

Immunology

What problem does this paper attempt to address?

This paper mainly discusses the production of anti-immune complex antibodies when using repeated HIV Env immunogens for immunization. The researchers discovered through polymeric epitope mapping that these antibodies target idiotopes, which are self-antigenic epitopes composed of antibody framework regions bound to HIV Env. The paper mentions four different types of anti-immune complex antibodies that are generated after multiple antigen exposures and may influence subsequent B-cell receptor (BCR) activation and secondary antibody production.

In the study, the authors used stabilized trimeric HIV Env immunogens, such as SOSIP immunogens, for experiments. They revealed the structure of these antibodies through electron microscopy-based polymeric epitope mapping. They observed that the antibodies can form complex interactions when binding to Env, including contacts between framework regions. These antibodies recognize and bind to framework regions of other antibodies rather than directly binding to neutralizing epitopes on Env.

The paper also indicates that the emergence of these anti-immune complex antibodies may provide insights for vaccine development, especially for pathogens that require multiple antigen exposures. They may be an example of the immune network theory, where antibodies induced by the initial antigen stimulation lead to the production of anti-idiotypic antibodies, which in turn may stimulate a broader range of antibody responses.

The research results highlight the necessity of considering immune complexity in vaccine design, as these non-neutralizing antibodies may compete or influence the production of functional antibodies. The authors suggest further studies to understand how these antibodies are induced by the immune system and whether they may affect B-cell receptors, potentially leading to pathological conditions. These findings may contribute to optimizing HIV vaccine strategies to more effectively induce broad-spectrum neutralizing antibodies.